Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Nearby (North Park, Canada, +266 more cities)

Research Site

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

fam-trastuzumab deruxtecan, +2 more drugs

targeted therapy

A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC

Nearby (North Park, Canada, +177 more cities)

Local Institution

Bladder Carcinoma

cisplatin, +3 more drugs

chemotherapy, +1 more type

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Nearby (North Park, Canada, +267 more cities)

Research Site

ER Negative, +2 more biomarkers

Breast Carcinoma

capivasertib, +1 more drug

chemotherapy, +1 more type

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

Nearby (North Park, Canada, +158 more cities)

Research Site

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

docetaxel, +4 more drugs

chemotherapy, +1 more type

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Nearby (North Park, Canada, +100 more cities)

Research Site

EGFR Exon 19 Deletion, +4 more biomarkers

Non-Small Cell Lung Carcinoma

osimertinib, +1 more drug

targeted therapy

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

~5 mi. (Toronto, Canada, +143 more cities)

Research Site

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

fam-trastuzumab deruxtecan, +3 more drugs

chemotherapy, +1 more type

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

~5 mi. (Toronto, Canada, +128 more cities)

Princess Margaret Cancer Centre University Health Network

Multiple Myeloma

bortezomib, +5 more drugs

cellular therapy, +4 more types

A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

~5 mi. (Toronto, Canada, +226 more cities)

Princess Margaret Cancer Centre University Health Network

EGFR Exon 19 Deletion, +1 more biomarker

Non-Squamous Non-Small Cell Lung Carcinoma

amivantamab, +3 more drugs

chemotherapy, +1 more type

A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

~5 mi. (Toronto, Canada, +133 more cities)

Princess Margaret Cancer Centre University Health Network

Multiple Myeloma

bortezomib, +4 more drugs

chemotherapy, +3 more types

Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

~5 mi. (Toronto, Canada, +247 more cities)

Local Institution, +1 more facility

ER Positive, +1 more biomarker

Breast Invasive Ductal Carcinoma

anthracycline, +4 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

~5 mi. (Toronto, Canada, +89 more cities)

North York General Hospital ( Site 0108), +1 more facility

ER Positive, +2 more biomarkers

Breast Carcinoma

capecitabine, +4 more drugs

chemotherapy, +1 more type

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~5 mi. (Toronto, Canada, +744 more cities)

Odette Cancer Centre- Sunnybrook Health Sciences Centre, +1 more facility

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type